A carregar...
Adalimumab in Treating Refractory Livedoid Vasculopathy
Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α agent adalimumab in three cases of refractory livedo...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2022-04-01
|
| Colecção: | Vaccines |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2076-393X/10/4/549 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|